- Home
- XOS vs CRIS Comparison
XOS vs CRIS Comparison
Compare XOS & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XOS
- CRIS
- Stock Information
- Founded
- XOS 2016
- CRIS 2000
- Country
- XOS United States
- CRIS United States
- Employees
- XOS N/A
- CRIS N/A
- Industry
- XOS Construction/Ag Equipment/Trucks
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- XOS Consumer Discretionary
- CRIS Health Care
- Exchange
- XOS Nasdaq
- CRIS Nasdaq
- Market Cap
- XOS 25.6M
- CRIS 21.3M
- IPO Year
- XOS N/A
- CRIS 2000
- Fundamental
- Price
- XOS $3.41
- CRIS $1.88
- Analyst Decision
- XOS Buy
- CRIS Strong Buy
- Analyst Count
- XOS 5
- CRIS 2
- Target Price
- XOS $8.80
- CRIS $16.50
- AVG Volume (30 Days)
- XOS 18.2K
- CRIS 172.7K
- Earning Date
- XOS 08-12-2025
- CRIS 07-31-2025
- Dividend Yield
- XOS N/A
- CRIS N/A
- EPS Growth
- XOS N/A
- CRIS N/A
- EPS
- XOS N/A
- CRIS N/A
- Revenue
- XOS $48,678,000.00
- CRIS $11,202,000.00
- Revenue This Year
- XOS $1.45
- CRIS N/A
- Revenue Next Year
- XOS $27.16
- CRIS $10.67
- P/E Ratio
- XOS N/A
- CRIS N/A
- Revenue Growth
- XOS N/A
- CRIS 14.17
- 52 Week Low
- XOS $2.73
- CRIS $1.02
- 52 Week High
- XOS $9.15
- CRIS $8.29
- Technical
- Relative Strength Index (RSI)
- XOS 61.59
- CRIS 42.69
- Support Level
- XOS $3.17
- CRIS $1.70
- Resistance Level
- XOS $3.50
- CRIS $2.01
- Average True Range (ATR)
- XOS 0.14
- CRIS 0.21
- MACD
- XOS 0.05
- CRIS -0.03
- Stochastic Oscillator
- XOS 82.60
- CRIS 38.78
About XOS Xos Inc.
Xos Inc is a fleet electrification solutions provider committed to the decarbonization of commercial transportation. Xos designs and manufactures Classes 5 through 8 battery-electric commercial vehicles that travel on last-mile, back-to-base routes of up to 200 miles per day. Xos also offers charging infrastructure products and services through Xos Energy Solutions to support electric vehicle fleets. Its products include Stepvan, MDXT, HDXT, Xosphere, and Xos Energy Solutions.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.